Wednesday, January 11, 2017

Obamacare helps you more than you know

In my continued rant about the likelihood of losing the Affordable Care Act, which allows diabetics like myself to rest easy knowing we'll always be able to get health care, here is another gem:

6 Lesser-Known Obamacare Provisions That Could Evaporate

Obamacare didn't just mandate that everyone needed health insurance, any more than it just set up a marketplace where people could buy health insurance policies directly.  It even did more than protect people with preexisting conditions, like diabetes (although I have to admit that is my favorite part of it).  There are also a number of things the ACA did for us that we're going to regret losing.

Monday, January 9, 2017

The truth about Obamacare

The Affordable Care Act, a.k.a. Obamacare, has been in the headlines a lot lately.  Republicans intend to repeal it once Trump takes office, and the only thing that remains to be seen is how quickly it'll happen.

This, of course, scares the hell out of me.  Obamacare is responsible for me being able to get health insurance at all.  I should address why this is sometime, and why I support the ACA with every fiber of my being, just in case some of you have forgotten what health insurance was like before the ACA was passed.  But not right now, as this particular post is about fact checking the claims about Obamacare.

Saturday, January 7, 2017


I have to apologize for having been silent so long, especially during all of the upheaval this fall.  Truth be told, I was despondent for a long time after the election, and the many headlines about the fate of the Affordable Care Act just made it worse.  I'm terrified for the fate of my health care, hell, for my health.

Wednesday, September 21, 2016

EpiPen price-gouging scandal brings a closer look at Mylan

I'm happy to say that the EpiPen price-gouging scandal has stirred enough outrage to trigger several investigations into Mylan.

Mylan CEO Heather Bresch was called in to testify before the House Oversight Committee today.  She's claiming that they're not price-gouging, that they only make $50 off of each pen...

Sunday, September 18, 2016

Price gouging on insulin is a thing, too

Remember the EpiPen price gouging story I posted not long ago?  It's funny, when I posted the story I said, "It's not related to diabetes."  But now that EpiPen prices have attracted such widespread attention, people have now brought up how much the cost of insulin has risen in recent years, too.

The EpiPen wasn't alone: Price gouging on insulin draws outrage

The rise in prices on insulin probably isn't quite as dramatic as the rise in EpiPen prices -- 200 percent on insulin, according to the Journal of the American Medical Association, contrasted with more like 500 percent on the EpiPen, but it's still a serious increase that we absolutely should be questioning.

Monday, August 29, 2016

Big Pharma price-gouging with EpiPens

It's not related to diabetes, but if you pay attention to the headlines at all lately, you probably heard about the latest scandal in the pharmaceutical world: Mylan has raised the price of their EpiPens something like 450 percent, from $100 for a two-pack in 2007 to $600 now.  And they can't even claim they have to cover the cost of inventing the drug, since they actually only bought the rights to the patent from another company.

So what have they been spending their money on?  Their CEO's salary, apparently, which has also jumped since then, from $2 million to $19 million.